Logo for Panbela Therapeutics Inc

Panbela Therapeutics Investor Relations Material

Latest events

Logo for Panbela Therapeutics Inc

Q4 2023

Panbela Therapeutics
Logo for Panbela Therapeutics

Q4 2023

26 Mar, 2024
Logo for Panbela Therapeutics

Q3 2023

9 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Panbela Therapeutics Inc

Access all reports
Panbela Therapeutics Inc, a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma.